eli lilly retatrutide study Phase 3 obesity trial results 2026 Eli Lilly's retatrutide cuts weight

Finally, among GLP-1 RA, the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) trial demonstrated a beneficial effect of weekly efpeglenatide on MACE and on a composite kidney outcome (decrease in kidney function or severe albuminuria) [247]

From recipes to real-talk strategies, I help people thrive through nurturing themselves from the inside out

Working on that third receptor may provide added effects for appetite inhibition and insulin sensitivity. In other words, it may help people lose more weight faster

Meet with the doctor for a telehealth appointment to review your lab results and discuss the details of your treatment plan